InsiderTrades.com logo

BMRN Insider Trading

Insider Ownership Percentage: 0.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $658,472.80

BioMarin Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Share Price & Price History

Current Price: $58.39
Price Change: ▲ Price Increase of +1.77 (3.13%)
As of 07/16/2025 05:00 PM ET

This chart shows the closing price history over time for BMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2025Erin BurkhartCAOSell1,786$59.31$105,927.6614,173View SEC Filing Icon  
5/2/2025Cristin HubbardEVPSell273$64.92$17,723.1632,700View SEC Filing Icon  
3/19/2025Erin BurkhartCAOSell1,295$71.52$92,618.4016,955View SEC Filing Icon  
2/24/2025Erin BurkhartCAOSell1,344$68.38$91,902.7213,105View SEC Filing Icon  
11/12/2024Charles Greg GuyerEVPSell5,278$66.37$350,300.8668,909View SEC Filing Icon  
5/30/2024Brian R. MuellerCFOSell5,000$75.19$375,950.0072,159View SEC Filing Icon  
5/28/2024George Eric DavisEVPSell40,850$74.51$3,043,733.5056,157View SEC Filing Icon  
5/9/2024Jean Jacques BienaimeDirectorSell20,000$81.62$1,632,400.00474,994View SEC Filing Icon  
5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.5056,157View SEC Filing Icon  
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00474,994View SEC Filing Icon  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.0016,156View SEC Filing Icon  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.6855,856View SEC Filing Icon  
3/5/2024Henry J. FuchsInsiderSell35,341$85.18$3,010,346.38212,117View SEC Filing Icon  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00561,203View SEC Filing Icon  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.0094,047View SEC Filing Icon  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00562,203View SEC Filing Icon  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00419,602View SEC Filing Icon  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00425,162View SEC Filing Icon  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00425,112View SEC Filing Icon  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.2055,710View SEC Filing Icon  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.0060,804View SEC Filing Icon  
8/10/2023Henry J. FuchsInsiderSell12,000$90.43$1,085,160.00176,187View SEC Filing Icon  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.0069,474View SEC Filing Icon  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00428,732View SEC Filing Icon  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00426,213View SEC Filing Icon  
4/10/2023Jean Jacques BienaimeCEOSell10,000$99.56$995,600.00425,896View SEC Filing Icon  
4/6/2023Jean Jacques BienaimeCEOSell10,000$96.13$961,300.00425,896View SEC Filing Icon  
4/3/2023V. Bryan LawlisDirectorSell8,500$97.09$825,265.0028,950View SEC Filing Icon  
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856View SEC Filing Icon  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856View SEC Filing Icon  
2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324View SEC Filing Icon  
2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324View SEC Filing Icon  
1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088View SEC Filing Icon  
1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424View SEC Filing Icon  
1/13/2023Brian R. MuellerCFOSell2,500$114.50$286,250.0027,746View SEC Filing Icon  
1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424View SEC Filing Icon  
12/13/2022Brian R. MuellerCFOSell2,500$107.50$268,750.0027,746View SEC Filing Icon  
12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424View SEC Filing Icon  
12/2/2022Brian R. MuellerCFOSell7,001$104.50$731,604.5027,746View SEC Filing Icon  
12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424View SEC Filing Icon  
11/23/2022Brian R. MuellerCFOSell5,379$98.73$531,068.6728,847View SEC Filing Icon  
11/2/2022Jeffrey Robert AjerEVPSell3,000$86.12$258,360.0041,088View SEC Filing Icon  
10/31/2022Jean Jacques BienaimeCEOSell1,500$86.55$129,825.00322,824View SEC Filing Icon  
10/31/2022Mark J. AllesDirectorBuy3,625$86.75$314,468.7510,905View SEC Filing Icon  
10/14/2022Jean Jacques BienaimeCEOSell4,000$89.89$359,560.00324,324View SEC Filing Icon  
8/15/2022Jean Jacques BienaimeCEOSell3,000$95.21$285,630.00328,324View SEC Filing Icon  
8/12/2022Jean Jacques BienaimeCEOSell4,000$94.75$379,000.00331,324View SEC Filing Icon  
8/11/2022Jeffrey Robert AjerEVPSell3,000$95.62$286,860.0044,088View SEC Filing Icon  
8/8/2022Charles Greg GuyerEVPSell6,205$96.56$599,154.8042,168View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/16/2025State of Alaska Department of Revenue21,565$1.19M0.0%-3.4%0.011%Search for SEC Filing on Google Icon
7/15/2025TD Private Client Wealth LLC504$28K0.0%-26.1%0.000%Search for SEC Filing on Google Icon
7/15/2025Public Employees Retirement System of Ohio59,895$3.29M0.0%+1.7%0.031%Search for SEC Filing on Google Icon
7/15/2025Fifth Third Bancorp1,604$88K0.0%-32.6%0.001%Search for SEC Filing on Google Icon
7/15/2025Covea Finance135,300$7.44M0.3%+27.3%0.071%Search for SEC Filing on Google Icon
7/14/2025GAMMA Investing LLC1,666$92K0.0%-46.8%0.001%Search for SEC Filing on Google Icon
7/11/2025UMB Bank n.a.1,935$0.11M0.0%-13.9%0.001%Search for SEC Filing on Google Icon
7/11/2025Assenagon Asset Management S.A.1,039,484$57.14M0.1%+28.5%0.542%Search for SEC Filing on Google Icon
7/11/2025Perpetual Ltd13,980$0.77M0.0%N/A0.007%Search for SEC Filing on Google Icon
7/11/2025IFM Investors Pty Ltd38,041$2.09M0.0%+4.4%0.020%Search for SEC Filing on Google Icon
7/10/2025Exchange Traded Concepts LLC21,617$1.19M0.0%+9.2%0.011%Search for SEC Filing on Google Icon
7/10/2025NorthCrest Asset Manangement LLC3,507$0.20M0.0%-28.2%0.002%Search for SEC Filing on Google Icon
7/10/2025Wealth Enhancement Advisory Services LLC74,381$4.28M0.0%+66.8%0.039%Search for SEC Filing on Google Icon
7/10/2025Wedmont Private Capital4,392$0.26M0.0%N/A0.002%Search for SEC Filing on Google Icon
7/10/2025Swedbank AB431,943$23.74M0.0%+0.5%0.225%Search for SEC Filing on Google Icon
7/10/2025Sumitomo Mitsui DS Asset Management Company Ltd20,387$1.12M0.0%-1.2%0.011%Search for SEC Filing on Google Icon
7/9/2025Sivia Capital Partners LLC4,439$0.24M0.1%+33.0%0.002%Search for SEC Filing on Google Icon
7/9/2025Pallas Capital Advisors LLC28,518$1.57M0.1%+10.8%0.015%Search for SEC Filing on Google Icon
7/8/2025Davis Investment Partners LLC7,789$0.44M0.2%-12.9%0.004%Search for SEC Filing on Google Icon
7/8/2025Parallel Advisors LLC474$26K0.0%-64.5%0.000%Search for SEC Filing on Google Icon
7/7/2025Wesbanco Bank Inc.35,000$1.92M0.1%+118.8%0.018%Search for SEC Filing on Google Icon
7/2/2025Central Pacific Bank Trust Division4,750$0.26M0.0%+9.2%0.002%Search for SEC Filing on Google Icon
7/1/2025Kera Capital Partners Inc.3,752$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
6/23/2025Swedbank AB429,843$30.39M0.0%-0.5%0.224%Search for SEC Filing on Google Icon
6/17/2025Howe & Rusling Inc.40,764$2.88M0.2%+3.6%0.021%Search for SEC Filing on Google Icon
5/28/2025Strs Ohio16,000$1.13M0.0%N/A0.008%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC24,011$1.70M0.0%-22.3%0.013%Search for SEC Filing on Google Icon
5/20/2025Intech Investment Management LLC32,132$2.27M0.0%-80.1%0.017%Search for SEC Filing on Google Icon
5/20/2025Focus Partners Wealth11,817$0.84M0.0%+70.2%0.006%Search for SEC Filing on Google Icon
5/19/2025Bayforest Capital Ltd7,808$0.55M0.2%N/A0.004%Search for SEC Filing on Google Icon
5/19/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC1,064,924$75.28M0.0%+0.9%0.555%Search for SEC Filing on Google Icon
5/16/2025Empowered Funds LLC12,023$0.85M0.0%+207.4%0.006%Search for SEC Filing on Google Icon
5/16/2025Meiji Yasuda Life Insurance Co10,451$0.74M0.0%-4.5%0.005%Search for SEC Filing on Google Icon
5/16/2025Meiji Yasuda Asset Management Co Ltd.12,025$0.85M0.0%-4.2%0.006%Search for SEC Filing on Google Icon
5/16/2025Clearline Capital LP281,053$19.87M1.2%-25.5%0.147%Search for SEC Filing on Google Icon
5/16/2025Fred Alger Management LLC28,803$2.04M0.0%+11.3%0.015%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.1,592,963$112.61M0.0%+212.7%0.831%Search for SEC Filing on Google Icon
5/16/2025Teza Capital Management LLC10,224$0.72M0.3%N/A0.005%Search for SEC Filing on Google Icon
5/16/2025Rise Advisors LLC430$30K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC277,252$19.60M2.3%N/A0.145%Search for SEC Filing on Google Icon
5/16/2025NFJ Investment Group LLC71,489$5.05M0.2%N/A0.037%Search for SEC Filing on Google Icon
5/16/2025Nissay Asset Management Corp Japan ADV23,536$1.66M0.0%+1.2%0.012%Search for SEC Filing on Google Icon
5/16/2025NewEdge Advisors LLC3,769$0.27M0.0%+11.5%0.002%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.52,489$3.72M0.0%-8.9%0.027%Search for SEC Filing on Google Icon
5/16/2025DnB Asset Management AS991,486$70.09M0.3%-0.2%0.517%Search for SEC Filing on Google Icon
5/16/2025Cinctive Capital Management LP28,736$2.03M0.2%N/A0.015%Search for SEC Filing on Google Icon
5/16/2025Alliancebernstein L.P.318,979$22.55M0.0%+23.9%0.166%Search for SEC Filing on Google Icon
5/16/2025Banque Transatlantique SA1,089$71K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC2,925,805$203.99M0.2%+127.9%1.526%Search for SEC Filing on Google Icon
5/16/2025Advisors Asset Management Inc.3,836$0.27M0.0%-9.2%0.002%Search for SEC Filing on Google Icon
5/16/2025Ancora Advisors LLC993$70K0.0%-23.2%0.001%Search for SEC Filing on Google Icon
5/15/2025Federation des caisses Desjardins du Quebec21,433$1.52M0.0%+48.1%0.011%Search for SEC Filing on Google Icon
5/15/2025Palo Alto Investors LP991,207$70.07M13.3%-7.1%0.517%Search for SEC Filing on Google Icon
5/15/2025EP Wealth Advisors LLC6,630$0.47M0.0%-7.2%0.003%Search for SEC Filing on Google Icon
5/15/2025PDT Partners LLC75,876$5.36M0.4%-14.4%0.040%Search for SEC Filing on Google Icon
5/15/2025Focus Partners Advisor Solutions LLC11,988$0.85M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC165,408$11.69M0.1%N/A0.086%Search for SEC Filing on Google Icon
5/15/2025Point72 Europe London LLP54,580$3.86M0.3%-10.1%0.028%Search for SEC Filing on Google Icon
5/15/2025Graham Capital Management L.P.19,017$1.34M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/15/2025Twin Tree Management LP51,280$3.63M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/15/2025Vident Advisory LLC6,046$0.43M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/15/2025Kodai Capital Management LP56,540$4M0.2%N/A0.029%Search for SEC Filing on Google Icon
5/15/2025Evergreen Capital Management LLC5,028$0.36M0.0%+33.0%0.003%Search for SEC Filing on Google Icon
5/15/2025Canada Pension Plan Investment Board481,600$34.04M0.0%+1.5%0.251%Search for SEC Filing on Google Icon
5/15/2025State of Wyoming5,801$0.41M0.1%+23.3%0.003%Search for SEC Filing on Google Icon
5/15/2025Trexquant Investment LP207,172$14.65M0.2%-5.4%0.108%Search for SEC Filing on Google Icon
5/15/2025Landscape Capital Management L.L.C.9,894$0.70M0.1%N/A0.005%Search for SEC Filing on Google Icon
5/15/2025Lansforsakringar Fondforvaltning AB publ 63,066$4.46M0.0%-5.1%0.033%Search for SEC Filing on Google Icon
5/15/2025OMERS ADMINISTRATION Corp30,067$2.13M0.0%+280.8%0.016%Search for SEC Filing on Google Icon
5/14/2025Ieq Capital LLC164,576$11.63M0.1%+173.0%0.086%Search for SEC Filing on Google Icon
5/14/2025Gamco Investors INC. ET AL8,290$0.59M0.0%-17.4%0.004%Search for SEC Filing on Google Icon
5/14/2025Gabelli Funds LLC16,800$1.19M0.0%-17.4%0.009%Search for SEC Filing on Google Icon
5/14/2025Rafferty Asset Management LLC134,218$9.49M0.0%-35.4%0.070%Search for SEC Filing on Google Icon
5/14/2025FORA Capital LLC5,025$0.36M0.0%+55.8%0.003%Search for SEC Filing on Google Icon
5/14/2025Caisse DE Depot ET Placement DU Quebec56,867$4.02M0.0%N/A0.030%Search for SEC Filing on Google Icon
5/14/2025Corebridge Financial Inc.210,495$14.88M0.1%-2.4%0.110%Search for SEC Filing on Google Icon
5/14/2025Freedom Investment Management Inc.5,684$0.40M0.0%+13.2%0.003%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC106,226$7.51M0.0%-1.1%0.055%Search for SEC Filing on Google Icon
5/14/2025Dodge & Cox14,955,240$1.06B0.6%+1.4%7.798%Search for SEC Filing on Google Icon
5/14/2025Jump Financial LLC46,200$3.27M0.0%+942.7%0.024%Search for SEC Filing on Google Icon
5/14/2025APG Asset Management N.V.186,867$12.23M0.0%+40.5%0.097%Search for SEC Filing on Google Icon
5/14/2025Smartleaf Asset Management LLC701$50K0.0%-20.8%0.000%Search for SEC Filing on Google Icon
5/14/2025Northwestern Mutual Wealth Management Co.13,218$0.93M0.0%-26.5%0.007%Search for SEC Filing on Google Icon
5/14/2025AlphaQuest LLC25,261$1.79M0.2%+145.0%0.013%Search for SEC Filing on Google Icon
5/14/2025Allstate Corp8,352$0.59M0.0%+49.3%0.004%Search for SEC Filing on Google Icon
5/14/2025Kaufman Rossin Wealth LLC6,519$0.46M0.3%N/A0.003%Search for SEC Filing on Google Icon
5/14/2025Candriam S.C.A.607,862$42.97M0.3%+4.8%0.317%Search for SEC Filing on Google Icon
5/14/2025Groupama Asset Managment12,818$0.92M0.0%-87.6%0.007%Search for SEC Filing on Google Icon
5/14/2025BI Asset Management Fondsmaeglerselskab A S12,695$0.90M0.0%-54.8%0.007%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC326,034$23M0.0%+66.7%0.170%Search for SEC Filing on Google Icon
5/14/2025Fuller & Thaler Asset Management Inc.836,397$59.13M0.2%N/A0.436%Search for SEC Filing on Google Icon
5/14/2025Quantbot Technologies LP8,044$0.57M0.0%+220.4%0.004%Search for SEC Filing on Google Icon
5/14/2025Korea Investment CORP214,903$15.19M0.0%+28.0%0.112%Search for SEC Filing on Google Icon
5/13/2025Qtron Investments LLC3,258$0.23M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/13/2025Northern Trust Corp1,696,864$119.95M0.0%-1.6%0.885%Search for SEC Filing on Google Icon
5/13/2025Brooklyn Investment Group564$40K0.0%+2,250.0%0.000%Search for SEC Filing on Google Icon
5/13/2025Algert Global LLC105,878$7.49M0.2%+151.5%0.055%Search for SEC Filing on Google Icon
5/13/2025State of New Jersey Common Pension Fund D63,276$4.47M0.0%-7.5%0.033%Search for SEC Filing on Google Icon
5/13/2025Sector Gamma AS137,348$9.71M3.1%-36.8%0.072%Search for SEC Filing on Google Icon
5/13/2025Aberdeen Group plc755,275$53.39M0.1%+8.5%0.394%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $58.39
Low: $56.82
High: $58.58

50 Day Range

MA: $57.27
Low: $54.08
High: $61.37

52 Week Range

Now: $58.39
Low: $52.93
High: $94.85

Volume

1,661,555 shs

Average Volume

1,754,182 shs

Market Capitalization

$11.20 billion

P/E Ratio

21.71

Dividend Yield

N/A

Beta

0.17

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Jeffrey Robert Ajer (EVP)
  5. Brian Mueller (CFO)
  6. George Eric Davis (EVP)
  7. Charles Greg Guyer (EVP)
  8. Cristin Hubbard (EVP)
  9. Erin Burkhart (CAO)
Learn More about top insider investors at BioMarin Pharmaceutical.

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Assenagon Asset Management S.A. — 0.54%
  2. Swedbank AB — 0.23%
  3. Covea Finance — 0.07%
  4. Wealth Enhancement Advisory Services LLC — 0.04%
  5. Public Employees Retirement System of Ohio — 0.03%
  6. IFM Investors Pty Ltd — 0.02%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. GAMMA Investing LLC
  2. NorthCrest Asset Manangement LLC
  3. Davis Investment Partners LLC
  4. Parallel Advisors LLC
  5. Fifth Third Bancorp
  6. UMB Bank n.a.
  7. Sumitomo Mitsui DS Asset Management Company Ltd
  8. TD Private Client Wealth LLC
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
Learn More investors selling BioMarin Pharmaceutical stock.

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Wealth Enhancement Advisory Services LLC
  3. Covea Finance
  4. Wesbanco Bank Inc.
  5. Perpetual Ltd
  6. Wedmont Private Capital
  7. Kera Capital Partners Inc.
  8. Pallas Capital Advisors LLC